World Heart Congress (WHC 2019)
November 21-22, 2019 | Hong Kong
Theme: current trends in cardiovascular research and technologies
About conference
World Heart Congress 2019 will mainly focus on Advance research in Cardiology
This Conference Highlights will follow a very innovative format.
Heart Disease
Cardiac Stem Cell Therapy
Heart Cell Regeneration
Website details
Conference Homepage: https://www.heartcongress.org/
Call for abstracts: https://www.heartcongress.org/call-for-abstract
Registration link: https://www.heartcongress.org/registration
Email: heart@infoconferences.com
Organization Name: Innovation Info
Whats App: +44 330 808 0101
Tel: +44 20 3807 2025
John Benson| Program Manager
for more CLICK HERE
November 21-22, 2019 | Hong Kong
Theme: current trends in cardiovascular research and technologies
The World Heart Congress to be held in Hong Kong from November 21-22,
2019 organized by Innovation Info Conferences, have a wide scope globally in guiding
cardiology students, cardiologists, scientists, research scholars, medical practitioners, leading
medical industries to champion professional and social relationship with sister organizations
and actively concur within the analysis and safe utilization of the medicine with honor and ethics.
World Heart Congress 2019 will mainly focus on Advance research in Cardiology
and Heart Diseases. As the annual event, we have developed a program with your
interests in mind. We have not only increased the number of opportunities for you
to network with colleagues from across the world, but also introduced more
focused sessions that will feature cutting edge keynote presentations, oral
presentations, poster presentations and livelier interaction with medical and clinical
leaders and experts.This Conference Highlights will follow a very innovative format.
- Clinical Cardiology
- Endovascular Intervention Technologies
- Pediatric & Geriatric Cardiology
- Stem Cell Research on Cardiology
- Molecular Cardiology and Research
- Brain-Heart Disorders and Neuroradiology
- Advances in Nuclear Cardiology
- Cardiovascular Pharmacology and Toxicology
Regenerative medicine and stem cell research have tremendous potential to revolutionize the treatment of cardiac disease. Research being conducted by members of the BSCRC may lead to discoveries that will reverse or repair heart muscle damage and offer clinical alternatives for the millions of Americans who are born with or develop heart disease.
For example, the heart has a limited ability to regenerate damaged tissue after a heart attack. Current drug therapies slow the progression of heart failure but are not curative and heart transplants can only be offered to a very limited number of patients. BSCRC faculty have focused their research on identifying cardiac stem cells and understanding the processes by which they turn into heart cells with the hopes of developing cell replacement therapies for regenerating heart muscle and lessoning
the need for transplantation.
Cardiac stem cells have the potential to differentiate into all the cells that make up the heart, including heart muscle cells, smooth muscle cells and endothelial cells. Additionally, our faculty have demonstrated that cardiac stem cells can be developed from iPSC, which we hope will allow an unlimited supply of personalized cardiac stem to be produced for each patient.
The Harvard Stem Cell Institute is developing new techniques to grow and transplant heart cells, replacing those lost to cardiovascular disease.
The greatest threat to the long-term health and well-being of people living with diabetes is cardiovascular disease. The diabetic population as a whole is two to four times more likely than non-diabetics to develop heart disease or suffer a stroke. Type 1 diabetes, which is most often diagnosed in childhood and adolescence, is particularly devastating, as one New England Journal of Medicine study associated it with a ten-fold increase in cardiovascular disease.
Harvard Stem Cell Institute (HSCI) investigators are developing ways to make replacement heart cells and provide them with the right cues so that the new cells play as needed in the orchestra. Stem cells are nature’s own transformers. When the body is injured, stem cells travel the scene of the accident. Some come from the bone marrow, a modest number of others, from the heart itself. Additionally, they’re not all the same. There, they may help heal damaged tissue. They do this by secreting local hormones to rescue damaged heart cells and occasionally turning into heart muscle cells themselves. Stem cells do a fairly good job. But they could do better – for some reason, the heart stops signaling for heart cells after only a week or so after the damage has occurred, leaving the repair job mostly undone. The partially repaired tissue becomes a burden to the heart, forcing it to work harder and less efficiently, leading to heart failure.
Both embryonic stem cells and induced pluripotent stem cells — mature cells that are manipulated back to a stem cell state — can be harnessed to create new heart cells. The difficulty is that the heart cells made with stem cells resemble the heart cells of an infant, rather than adult heart cells. To function in adult hearts, the new heart cells must “mature” and then be able to survive within the constantly beating environment of the heart.
The scientific community has generated the technology to make heart cells that are immature, but very few heart cells derived from stem cells integrate into the normal heart tissue as mature heart cells. At the HSCI, our researchers are focused on understanding how to take these new heart cells all the way to maturity and stability, so they can be used as an effective therapy.
Cardiac regeneration is a broad effort that aims to repair irreversibly damaged heart tissue with cutting-edge science, including stem cell and cell-free therapy. Reparative tools have been engineered to restore damaged heart tissue and function using the body's natural ability to regenerate. Working together, patients and providers are finding regenerative solutions that restore, renew and recycle patients own reparative capacity. Through the vision and generous support of Russ and Kathy Van Cleve, strong efforts are underway to develop discoveries that will have a global impact on ischemic
heart disease.
Mayo Clinic researchers are leading efforts in translating new knowledge into applicable therapeutics through a multidisciplinary community of practice. As technology evolves, it offers the potential to regenerate cardiac tissue from non-cardiac sources and ultimately provide personalized products and services to people with cardiovascular disease.
Conference Homepage: https://www.heartcongress.org/
Call for abstracts: https://www.heartcongress.org/call-for-abstract
Registration link: https://www.heartcongress.org/registration
Email: heart@infoconferences.com
Organization Name: Innovation Info
Whats App: +44 330 808 0101
Tel: +44 20 3807 2025
John Benson| Program Manager
for more CLICK HERE
